CVS Health Corporation (SNSE:CVS)
78.63
0.00 (0.00%)
At close: Mar 6, 2026
CVS Health Ratios and Metrics
Market cap in millions CLP. Fiscal year is January - December.
Millions CLP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 89,799,515 | 90,745,517 | 56,135,162 | 89,085,444 | 104,026,188 | 116,105,755 | Upgrade
|
| Market Cap Growth | 16.07% | 61.66% | -36.99% | -14.36% | -10.40% | 82.79% | Upgrade
|
| Enterprise Value | 152,775,597 | 154,431,758 | 128,861,554 | 145,265,897 | 147,702,403 | 172,445,959 | Upgrade
|
| Last Close Price | 71228.56 | 70228.53 | 42889.36 | 55744.74 | 70128.75 | 73969.43 | Upgrade
|
| PE Ratio | 56.39 | 56.98 | 12.24 | 12.18 | 28.40 | 17.03 | Upgrade
|
| PS Ratio | 0.25 | 0.25 | 0.15 | 0.28 | 0.38 | 0.47 | Upgrade
|
| PB Ratio | 1.32 | 1.34 | 0.75 | 1.33 | 1.71 | 1.81 | Upgrade
|
| P/FCF Ratio | 12.77 | 12.90 | 8.93 | 9.78 | 9.10 | 8.65 | Upgrade
|
| P/OCF Ratio | 9.37 | 9.47 | 6.20 | 7.57 | 7.57 | 7.46 | Upgrade
|
| EV/Sales Ratio | 0.42 | 0.43 | 0.35 | 0.47 | 0.54 | 0.70 | Upgrade
|
| EV/EBITDA Ratio | 9.56 | 11.72 | 10.28 | 8.99 | 8.71 | 10.86 | Upgrade
|
| EV/EBIT Ratio | 16.83 | 17.11 | 16.17 | 11.77 | 11.04 | 14.30 | Upgrade
|
| EV/FCF Ratio | 21.72 | 21.96 | 20.50 | 15.94 | 12.93 | 12.86 | Upgrade
|
| Debt / Equity Ratio | 1.06 | 1.06 | 1.10 | 1.04 | 0.99 | 1.01 | Upgrade
|
| Debt / EBITDA Ratio | 4.53 | 4.53 | 5.30 | 3.68 | 3.06 | 3.48 | Upgrade
|
| Debt / FCF Ratio | 10.24 | 10.24 | 13.11 | 7.64 | 5.26 | 4.83 | Upgrade
|
| Net Debt / Equity Ratio | 0.92 | 0.92 | 0.95 | 0.89 | 0.77 | 0.84 | Upgrade
|
| Net Debt / EBITDA Ratio | 4.74 | 4.74 | 5.70 | 3.68 | 2.76 | 3.41 | Upgrade
|
| Net Debt / FCF Ratio | 8.88 | 8.88 | 11.37 | 6.54 | 4.09 | 4.03 | Upgrade
|
| Asset Turnover | 1.58 | 1.58 | 1.47 | 1.49 | 1.40 | 1.25 | Upgrade
|
| Inventory Turnover | 18.56 | 18.56 | 17.79 | 16.35 | 14.54 | 13.24 | Upgrade
|
| Quick Ratio | 0.57 | 0.57 | 0.56 | 0.59 | 0.62 | 0.55 | Upgrade
|
| Current Ratio | 0.84 | 0.84 | 0.81 | 0.86 | 0.95 | 0.89 | Upgrade
|
| Return on Equity (ROE) | 2.29% | 2.29% | 6.02% | 11.28% | 5.88% | 11.01% | Upgrade
|
| Return on Assets (ROA) | 2.47% | 2.47% | 1.99% | 3.68% | 4.27% | 3.82% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.62% | 5.54% | 4.09% | 7.77% | 8.79% | 7.59% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.10% | 6.10% | 4.80% | 8.30% | 9.90% | 8.60% | Upgrade
|
| Earnings Yield | 1.77% | 1.75% | 8.17% | 8.21% | 3.52% | 5.87% | Upgrade
|
| FCF Yield | 7.83% | 7.75% | 11.20% | 10.23% | 10.98% | 11.55% | Upgrade
|
| Dividend Yield | 3139.75% | 3.41% | 6.16% | 3.81% | 2.67% | 2.30% | Upgrade
|
| Payout Ratio | 192.14% | 192.14% | 73.10% | 37.54% | 67.43% | 32.81% | Upgrade
|
| Buyback Yield / Dilution | -0.71% | -0.71% | 2.17% | 2.49% | 0.45% | -1.14% | Upgrade
|
| Total Shareholder Return | 3139.04% | 2.70% | 8.33% | 6.30% | 3.12% | 1.16% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.